Biotech · Private company · Emeryville, CA, US
Dynavax Technologies Corp
SEC CIK 0001029142
Track this companyFree. Adds Dynavax Technologies Corp to your Dealase workspace and tells you when its record changes.
Clinical trials181 recruiting or active
Pipeline programs27From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline27
- Engerix-BPhase 3 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Engerix-BPhase 3 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- HEPLISAVPhase 3 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- HEPLISAV-BPhase 3 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Amb a 1 immunostimulatory oligodeoxyribonucleotide conjugatePhase 2 · Rhinitis, Allergic, SeasonalClinicalTrials.gov · fetched Nov 12, 2026
- HEPLISAVPhase 2 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- Histamine basePhase 2 · Rhinitis, Allergic, SeasonalClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Radiation therapyPhase 2 · B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- rF1V vaccinePhase 2 · Plague, PneumonicClinicalTrials.gov · fetched Nov 12, 2026
- rF1V-1018Phase 2 · Plague, PneumonicClinicalTrials.gov · fetched Nov 12, 2026
- rF1V-1018Phase 2 · Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia PestisClinicalTrials.gov · fetched Nov 12, 2026
- SD-101Phase 2 · B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- SD-101(1)Phase 2 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- SD-101(2)Phase 2 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- SD-101(3)Phase 2 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- 1018 ISS immunostimulatory oligonucleotidePhase 1 · Colorectal NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- 1018 ISS immunostimulatory oligonucleotide with HBV surface antigenPhase 1 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- Approved Anti-PD-1 InhibitorPhase 1 · Advanced Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Breath Actuated NebulizerPhase 1 · Advanced Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- DV281Phase 1 · Advanced Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- DV281 (RP2D)Phase 1 · Advanced Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Hepatitis B Vaccine (Recombinant)Phase 1 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- HEPLISAV-B®Phase 1 · End Stage Renal Disease on Hemodialysis (Diagnosis)ClinicalTrials.gov · fetched Nov 12, 2026
- SD-101Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- HEPLISAVChronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- HEPLISAV-BPregnantClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials18
- Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of AgePHASE2 · ACTIVE_NOT_RECRUITING · started Sep 11, 2025ClinicalTrials.gov NCT07207408 · fetched Nov 12, 2026
- Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of AgePHASE2 · COMPLETED · started Aug 9, 2022ClinicalTrials.gov NCT05506969 · fetched Nov 12, 2026
- DV2-HBV-27: Observational Pregnancy RegistryUNKNOWN · started Feb 21, 2021ClinicalTrials.gov NCT03664648 · fetched Nov 12, 2026
- SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic CancerPHASE1 · COMPLETED · started Aug 15, 2019ClinicalTrials.gov NCT04050085 · fetched Nov 12, 2026
- HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing HemodialysisPHASE1 · COMPLETED · started Apr 22, 2019ClinicalTrials.gov NCT03934736 · fetched Nov 12, 2026
- Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLCPHASE1 · COMPLETED · started Sep 20, 2017ClinicalTrials.gov NCT03326752 · fetched Nov 12, 2026
- A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaPHASE1_PHASE2 · TERMINATED · started Sep 1, 2015ClinicalTrials.gov NCT02521870 · fetched Nov 12, 2026
- Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell LymphomaPHASE1_PHASE2 · TERMINATED · started Oct 1, 2014ClinicalTrials.gov NCT02266147 · fetched Nov 12, 2026
- Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® VaccinePHASE3 · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02117934 · fetched Nov 12, 2026
- A Study of the Immune Response to Heplisav in Healthy Older AdultsPHASE1 · COMPLETED · started Nov 1, 2013ClinicalTrials.gov NCT01999699 · fetched Nov 12, 2026
- Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney DiseaseCOMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01282762 · fetched Nov 12, 2026
- Safety and Immunogenicity Study of the Hepatitis B Virus (HBV) Vaccine, HEPLISAV Compared to Engerix-B VaccinePHASE3 · COMPLETED · started Feb 1, 2010ClinicalTrials.gov NCT01005407 · fetched Nov 12, 2026
- Comparing Safety and Immunogenicity of HEPLISAV-B® to Engerix-B® in Chronic Kidney Disease (CKD) PatientsPHASE3 · COMPLETED · started Sep 1, 2009ClinicalTrials.gov NCT00985426 · fetched Nov 12, 2026
- Safety, Pharmacokinetics, and Pharmacodynamics of SD-101 in Healthy Normal MalesPHASE1 · COMPLETED · started Jan 1, 2008ClinicalTrials.gov NCT00599001 · fetched Nov 12, 2026
- Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus VaccinePHASE2 · COMPLETED · started Jun 1, 2007ClinicalTrials.gov NCT00511095 · fetched Nov 12, 2026
- A Study of 1018 Immunostimulatory Sequence (ISS) Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal CancerPHASE1 · TERMINATED · started Nov 1, 2006ClinicalTrials.gov NCT00403052 · fetched Nov 12, 2026
- Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic AdultsPHASE2 · TERMINATED · started Apr 1, 2006ClinicalTrials.gov NCT00387738 · fetched Nov 12, 2026
- Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure PatientsPHASE1 · COMPLETED · started Jan 1, 2006ClinicalTrials.gov NCT00426712 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Feb 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 29, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 5, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 5, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 16, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 21, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 7, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 7, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 17, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 13, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 6, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 6, 2025 · fetched Nov 12, 2026